Literature DB >> 22617060

Multiparametric MRI and prostate cancer diagnosis and risk stratification.

Baris Turkbey1, Peter L Choyke.   

Abstract

PURPOSE OF REVIEW: Prostate cancer is the most common solid organ cancer type among American men. Screening and imaging aim to detect early-stage disease that is biologically aggressive. The focus of this study is to review multiparametric MRI in the detection and risk stratification of prostate cancer. RECENT
FINDINGS: MP-MRI has been shown to be the most accurate noninvasive technique to localize prostate cancer. Recent studies reported that using MRI for guidance during prostate biopsies increases the yield of prostate biopsies. Moreover, multiparametric and particular MRI sequences such as apparent diffusion coefficient values of diffusion-weighted MRI have been found to correlate negatively with tumor Gleason scores.
SUMMARY: Among the existing imaging modalities, multiplanar magnetic resonance is the best at detecting prostate cancers. Some risk stratification is possible based on size, extent and apparent diffusion coefficient values. However, prostate MRI remains nonspecific and biopsies must be performed to confirm whether an abnormality is benign or malignant and to assign Gleason scores.

Entities:  

Mesh:

Year:  2012        PMID: 22617060      PMCID: PMC6309696          DOI: 10.1097/MOU.0b013e32835481c2

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  38 in total

1.  Endorectal MR imaging before salvage prostatectomy: tumor localization and staging.

Authors:  Evis Sala; Steven C Eberhardt; Oguz Akin; Chaya S Moskowitz; Chinyere N Onyebuchi; Kentaro Kuroiwa; Nicole Ishill; Michael J Zelefsky; James A Eastham; Hedvig Hricak
Journal:  Radiology       Date:  2006-01       Impact factor: 11.105

2.  Diffusion imaging of the prostate at 3.0 tesla.

Authors:  Peter Gibbs; Martin D Pickles; Lindsay W Turnbull
Journal:  Invest Radiol       Date:  2006-02       Impact factor: 6.016

3.  Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers.

Authors:  Jurgen J Fütterer; Marc R Engelbrecht; Henkjan J Huisman; Gerrit J Jager; Christina A Hulsbergen-van De Kaa; J Alfred Witjes; Jelle O Barentsz
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

4.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.

Authors:  A E Wefer; H Hricak; D B Vigneron; F V Coakley; Y Lu; J Wefer; U Mueller-Lisse; P R Carroll; J Kurhanewicz
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

5.  Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis.

Authors:  Evis Sala; Oguz Akin; Chaya S Moskowitz; Halley F Eisenberg; Kentaro Kuroiwa; Nicole M Ishill; Balashanmugam Rajashanker; Peter T Scardino; Hedvig Hricak
Journal:  Radiology       Date:  2006-01-19       Impact factor: 11.105

6.  Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging.

Authors:  Fergus V Coakley; John Kurhanewicz; Ying Lu; Kirk D Jones; Mark G Swanson; Silvia D Chang; Peter R Carroll; Hedvig Hricak
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

7.  Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer.

Authors:  Jun Nakashima; Akihiro Tanimoto; Yutaka Imai; Makio Mukai; Yutaka Horiguchi; Ken Nakagawa; Mototsugu Oya; Takashi Ohigashi; Ken Marumo; Masaru Murai
Journal:  Urology       Date:  2004-07       Impact factor: 2.649

8.  Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings.

Authors:  Olivier Rouvière; Olivier Valette; Stéphanie Grivolat; Catherine Colin-Pangaud; Raymonde Bouvier; Jean Yves Chapelon; Albert Gelet; Denis Lyonnet
Journal:  Urology       Date:  2004-05       Impact factor: 2.649

9.  Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.

Authors:  Liang Wang; Michael Mullerad; Hui-Ni Chen; Steven C Eberhardt; Michael W Kattan; Peter T Scardino; Hedvig Hricak
Journal:  Radiology       Date:  2004-05-27       Impact factor: 11.105

Review 10.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

View more
  37 in total

Review 1.  Individualized image-based lymph node irradiation for prostate cancer.

Authors:  Hanneke J M Meijer; Oscar A Debats; Emile N J Th van Lin; Marco van Vulpen; J Alfred Witjes; Wim J G Oyen; Jelle O Barentsz; Johannes H A M Kaanders
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

2.  Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.

Authors:  Meredith Sadinski; Gregory Karczmar; Yahui Peng; Shiyang Wang; Yulei Jiang; Milica Medved; Ambereen Yousuf; Tatjana Antic; Aytekin Oto
Journal:  AJR Am J Roentgenol       Date:  2016-06-28       Impact factor: 3.959

3.  B-mode and acoustic radiation force impulse (ARFI) imaging of prostate zonal anatomy: comparison with 3T T2-weighted MR imaging.

Authors:  Mark L Palmeri; Zachary A Miller; Tyler J Glass; Kirema Garcia-Reyes; Rajan T Gupta; Stephen J Rosenzweig; Christopher Kauffman; Thomas J Polascik; Andrew Buck; Evan Kulbacki; John Madden; Samantha L Lipman; Ned C Rouze; Kathryn R Nightingale
Journal:  Ultrason Imaging       Date:  2014-07-23       Impact factor: 1.578

Review 4.  Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment.

Authors:  Marc A Bjurlin; Xiaosong Meng; Julien Le Nobin; James S Wysock; Herbert Lepor; Andrew B Rosenkrantz; Samir S Taneja
Journal:  J Urol       Date:  2014-04-21       Impact factor: 7.450

5.  Is it time to reevaluate definitive therapy in prostate cancer?

Authors:  Ravi A Madan; Avni A Shah; William L Dahut
Journal:  J Natl Cancer Inst       Date:  2013-04-24       Impact factor: 13.506

Review 6.  [Precision of prostate magnetic resonance imaging for the detection of clinically significant prostate cancer].

Authors:  U Krafft; A Borkowetz
Journal:  Urologe A       Date:  2020-01       Impact factor: 0.639

Review 7.  Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective.

Authors:  Tobias Penzkofer; Clare M Tempany-Afdhal
Journal:  NMR Biomed       Date:  2013-09-03       Impact factor: 4.044

8.  Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer.

Authors:  Soroush Rais-Bahrami; Baris Turkbey; Kinzya B Grant; Peter A Pinto; Peter L Choyke
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

Review 9.  Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies.

Authors:  Jennifer K Logan; Soroush Rais-Bahrami; Baris Turkbey; Andrew Gomella; Hayet Amalou; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  BJU Int       Date:  2014-05-22       Impact factor: 5.588

10.  Prostate diffusion-weighted imaging at 3T: effect of intravenous gadobutrol administration.

Authors:  Chan Kyo Kim; Jung Jae Park; Byung Kwan Park
Journal:  Eur Radiol       Date:  2015-08-09       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.